Figure 2From: Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheresValidation of CNV Assay by array-CGH analysis. A) Trisomy of chromosome 7, but not EGFR amplification (probe position at +0.40), in BT314. B) Complete loss of chromosome 14q in BT314 (probe position at -0.40/-0.60); C) EGFR amplification in primary tumor BT418 (probe position at +0.60).Back to article page